Follow

4D PHARMA PLC

London AIM (United Kingdom)

We are pioneers in harnessing bacteria as a novel and revolutionary class of medicines: Live Biotherapeutics.

Sector:
HEALTH CARE
News
01 Apr 2021 - 08:00
25 Mar 2021 - 08:00
22 Mar 2021 - 07:00
03 Mar 2021 - 07:00
26 Feb 2021 - 07:02
16 Feb 2021 - 07:00
08 Feb 2021 - 07:45
08 Feb 2021 - 07:00
1 2 3 4 5
Show

10

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
DDDD ORD 0.25P
GB00BJL5BR07
London AIM
United Kingdom (GB)
Details of share in 4D PHARMA PLC with ticker DDDD ORD 0.25P
Status
Active
Amount of instruments
Currency
Segment
AMSM
Type
Price
Pre-money
Time
Files
Listing
100 pence
36.55M GBP
18 Feb 2014
Direct listing of 4D PHARMA PLC on London AIM
Type
Price
Pre-money
Time
Files
New issue
150 pence
55.87M GBP
14 Jul 2014
Share issue in 4D PHARMA PLC
Type
Price
Pre-money
Time
Files
New issue
790 pence
478.49M GBP
08 Dec 2015
Share issue in 4D PHARMA PLC
Type
Price
Pre-money
Time
Files
Directed issue
9.805 GBP
635.13M GBP
08 Apr 2016
Share issue in 4D PHARMA PLC
Type
Price
Pre-money
Time
Files
New issue
50 pence
32.75M GBP
18 Feb 2020
Share issue in 4D PHARMA PLC
Type
Price
Pre-money
Time
Files
New issue
35 pence
38.32M GBP
13 Jul 2020
Share issue in 4D PHARMA PLC
Type
Price
Pre-money
Time
Files
Private placement
1.10 GBP
144.72M GBP
18 Mar 2021
Share issue in 4D PHARMA PLC
People
Duncan Peyton
CEO
Axel Glasmacher
Chairman of the board
Alex Stevenson
Board member
Ed Baracchini
Board member
Sandy Macrae
Board member
Katrin Rupalla
Board member
Company Details
Sector
HEALTH CARE

Address
9 BOND COURT
Zip code
LS1 2JZ
City/district
Leeds
Country
United Kingdom (GB)
Registration number
08840579
LEI code
213800O49VYSXWE2ZD52
First trade date
18 Feb 2014
Company former names
4D PHARMA LIMITED
07 Feb 2014
SCHOSWEEN 18 LIMITED
31 Jan 2014
Registration date
10 Jan 2014
Short name
4D PHARMA

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More